SRAX Launches Microcaps.com

SRAX, Inc. (NASDAQ:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has launched Microcaps.com, an editorial content and curated news

SRAX, Inc. (NASDAQ:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has launched Microcaps.com, an editorial content and curated news distribution site.

Microcaps.com will feature syndicated press releases and news, as well as investor-facing articles highlighting the microcaps community. The goal is to provide increased exposure and awareness for companies, in addition to information, news, and resources for small and microcap investors.

Microcaps.com’s main purpose will be to benefit the growing Sequire Investor Community as an information hub and interactive environment for the investor network. By aggregating relevant information for microcap investors, Microcaps.com will become a go-to resource.

“We are creating this website to serve the entire microcap community,” said Christopher Miglino, Founder and CEO of SRAX. “We are committed to building products that enhance exposure for public companies, and microcaps.com is a great example of the new tools we’re creating to gain more exposure for public issuers.”

Visit Microcaps.com now.

Total
0
Shares
Related Posts
Read More

UPDATE: CureVac, GlaxoSmithKline Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study (Body Of This Headline Contains Contents Of Press Release)

- Vaccine candidate combining Beta- and Delta-specific mRNAs shows strong protection and immune responses during preclinical challenge study - Demonstrated neutralizing capacity against the Omicron variant in vaccinated

CVAC